GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Net Issuance of Preferred Stock

LumiraDx (LumiraDx) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

LumiraDx's net issuance of preferred for the three months ended in Jun. 2023 was $0.0 Mil. The number is 0, which means that LumiraDx has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

LumiraDx's net issuance of preferred for the trailing twelve months (TTM) ended in Jun. 2023 was $0.0 Mil.


LumiraDx Net Issuance of Preferred Stock Historical Data

The historical data trend for LumiraDx's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Net Issuance of Preferred Stock Chart

LumiraDx Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Net Issuance of Preferred Stock
- 162.40 - -

LumiraDx Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

LumiraDx Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LumiraDx Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of LumiraDx's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


LumiraDx (LumiraDx) Business Description

Traded in Other Exchanges
N/A
Address
C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108
LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.